Chiara Pensa

ORCID: 0000-0003-1450-4333
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hidradenitis Suppurativa and Treatments
  • Autoimmune Bullous Skin Diseases
  • Nonmelanoma Skin Cancer Studies
  • Colorectal and Anal Carcinomas
  • Chemotherapy-related skin toxicity
  • Dermatologic Treatments and Research
  • Immunodeficiency and Autoimmune Disorders
  • Cancer and Skin Lesions
  • Urticaria and Related Conditions
  • Dermatology and Skin Diseases
  • Hair Growth and Disorders
  • Cancer Genomics and Diagnostics
  • Inflammatory Bowel Disease
  • Mental Health Research Topics
  • Cutaneous Melanoma Detection and Management
  • Anorectal Disease Treatments and Outcomes
  • Optical Coherence Tomography Applications
  • Biosimilars and Bioanalytical Methods
  • Congenital Heart Disease Studies
  • Congenital heart defects research
  • Coronary Artery Anomalies
  • Plant Pathogens and Fungal Diseases
  • Hereditary Neurological Disorders
  • Microscopic Colitis
  • Autoimmune and Inflammatory Disorders

The University of Texas Health Science Center at Houston
2024

University of Rome Tor Vergata
2020-2024

Policlinico Tor Vergata
2021

Marconi University
2020

Central Michigan University
2020

Michigan United
2020

In Western countries, the number of individuals suffering from an autoimmune condition is constantly growing and often patients disease are susceptible to developing a second disorder. We report case adult female patient affected by psoriasis vulgaris treated with tildrakizumab, humanized monoclonal antibody targeting interleukin-23, who later developed chronic spontaneous urticaria started omalizumab, IgE, showing favorable outcome. speculate that two combined therapies have restored...

10.1111/dth.15359 article EN Dermatologic Therapy 2022-02-09

Background ABP 501 is a biosimilar to the anti-tumor necrosis factor-alfa monoclonal antibody adalimumab and despite its effectiveness safety in treatment of psoriasis was demonstrated randomized clinical trials, no real-life data are available, particular patients undergoing non-medical switch from originator biosimilar.Methods We retrospectively searched our records for all receiving between March 10, 2019 September 7, at Department. Therefore, we identified 94 patients, 46 underwent...

10.1080/03007995.2021.1923467 article EN Current Medical Research and Opinion 2021-05-20

article: Baricitinib effectiveness in patients with alopecia universalis and rheumatoid arthritis - Italian Journal of Dermatology Venereology 2022 December;157(6):535-6 Minerva Medica Journals

10.23736/s2784-8671.22.07348-0 article EN Italian Journal of Dermatology and Venereology 2023-01-01

Intralesional steroid injection is a treatment method frequently used to resolve large number of orthopedic, rheumatological, dermatological, and neurological disorders. Although this very effective, it not without possible side effects, both systemic local, among which we can mention pain, bleeding, ulceration, atrophy, pigmentary changes, calcification, secondary infections, formation granulomas, allergic reactions and, in rare cases, the development linear hypopigmentation. Here, present...

10.1111/dth.14526 article EN Dermatologic Therapy 2020-11-01

article: May COVID-19 infection induce a paradoxical improvement of non-responsive case hidradenitis suppurativa? - Italian Journal Dermatology and Venereology 2021 October;156(5):616-7 Minerva Medica Journals

10.23736/s2784-8671.21.07076-6 article EN Italian Journal of Dermatology and Venereology 2021-07-20

Bicuspid aortic valve (BAV) is the most common congenital heart defect in adults, often leading to complications such as thoracic aneurysms and stenosis. While BAV frequently associated with 22q11.2 deletion syndrome (22q11.2DS), contribution of rare copy number variants (CNVs) this region non-syndromic less clear. This study aimed assess role CNVs patients early-onset (EBAV) determine whether these are linked an increased risk complications.

10.1136/heartjnl-2024-324669 article EN Heart 2024-12-10

C.P., M.B., A.Z., and A.P. were involved in direct management of the patient drafted first manuscript reviewed literature. A.Z. supervised drafting. All authors read approved final manuscript. Data available on request from authors.

10.1111/dth.14371 article EN Dermatologic Therapy 2020-10-06

In Western countries the number of individuals suffering from an autoimmune condition is constantly growing and often patients disease are susceptible to developing a second disorder. We report case adult female patient affected by psoriasis vulgaris treated with tildrakizumab, humanized monoclonal antibody targeting interleukin-23, who later developed chronic spontaneous urticaria started omalizumab, IgE, showing favorable outcome. speculate that two combined therapies have restored...

10.52768/2766-7820/1251 article EN Journal of Clinical Images and Medical Case Reports 2021-07-31
Coming Soon ...